PROGRESSive Withdrawal Esomeprazole and Acid-related Symptoms
NCT02476097
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
58
Enrollment
OTHER
Sponsor class
Conditions
Stomach Diseases
Interventions
DRUG:
Esomeprazole: Nexium® 20mg, Astra Zeneca
OTHER:
CYP2C19 phenotypical analysis
DRUG:
Placebo
Sponsor
Victoria Rollason